LB-2 | VEGF Gene Therapy Improves Exercise Time, Ischemia, and Symptoms in Patients with Refractory Angina: Results of the Phase II EXACT Trial
Title:
LB-2 | VEGF Gene Therapy Improves Exercise Time, Ischemia, and Symptoms in Patients with Refractory Angina: Results of the Phase II EXACT Trial
Author:
Nakamura, Kenta Henry, Timothy D. Traverse, Jay H. Latter, David A. Mokadam, Nahush A. Answini, Geoffrey A. Williams, Adam R. Sun, Benjamin Burke, Christopher R. Bakaeen, Faisal G. DiCarli, Marcelo F. Chaitman, Bernard R. Peterson, Mark W. Byrnes, Dawn G. Ohman, E.M. Pepine, Carl J. Crystal, Ronald G. Rosengart, Todd K. Kowalewski, Elaine Koch, Gary G. Dittrich, Howard C. Povsic, Thomas Joseph
Appeared in:
Journal of the Society for Cardiovascular Angiography & Interventions